Respiratory Disease Flashcards
Respiratory Tract System
- most common entry point for infections
- upper tract- mouth nose, nasal cavity, sinuses, throat, epiglottis and larynx
- lower tract- trachea, bronchi, and bronchioles in the lungs
- no normal flora, free of microbes
common infections
- pharyngitis- sore throat
- laryngitis- S. pneumoniae, S. pyogenes, viruses
- Tonsillitis- same as above
- Sinusitis- S. pneumoniae, H. influenzae
- Epiglottis- H. influenczae type b; life threatening; fast moving
streptococcal pharyngitis
- S. pyogenes
- Group A beta hemolytic strep
- Virulence factors
- streptokinases- lyse fibrin clots (breakdown clots)
- streptlusins- cytotoxic to tissue cells and lyse (break open RBC)
- M protein- resist phagocytosis
Streptococcus pharyngitis
- inflammation and fever
- ear infections are complication
- respiratory route
- indirect latex agglutination (test)
- should treat with antibiotics
Diphtheria
- Corynrbacterium diptheriae
- was leading cause of death in children before vaccine, DPT
- vaccine is a toxoid
- most of the damage of this organism caused by exotoxin produced in lysogenized strains
Diphtheria vs. Strep
Diphtheria- inflamed pharynx and tonsils marked by grayish pseudomembrane formed by the bacteria are characteristic signs of diphtheria
strep- white patches on throat
mechanisms of of A-B toxin of Corynebacterium
- one of most potent exotoxins
-toxin interferes with protein synthesis; damages kidneys, heart etc. - antitoxins must be used with antibiotics
-Pseudomembrane
-sub-clinical infections
respiratory route
herd immunity
Whopping Cough
- Bordetella pertussis
- Gm neg, coccobacillus, capsule, destroys the ciliated cells of trachea
- Tracheal toxin- ciliated cells
- Pertussis toxin- systemic toxin
- highly contagious
- vaccine- reactions to whole cell vaccine
- respiratory route
- new vaccine is acellular and causes fewer reactions: DTaP –> aP is acellular pertussis
Pneumonia
viral, bacterial and fungal
Pneumococcal pneumoniae
- S. pneumoniae, Gm pos diplococci, capsule
- high fever, breathing difficulty and chest pain
- involves both bronchi and alveoli
- vaccine- purified
bacteria
Mycoplasma pneumoniae
- no cell walls
- require growth factors to culture
- low fever, cough, head ache 3-6 weeks
- walking pneumonia
- primary atypical (not as severe)
Influenza
- influenza virus; many serotypes
- chills, muscle aches
- US:
- 5% to 20% gets the flu
- more then 200,000 get hospitalized
- 36,00 die
Antigenic changes
- strains typed based on antigens
- N= neuraminidase
- H = hemagglutinin
Antigenic drift- gradual changes in the antigens on virus
Antigenic shift- major shift in antigens, could be from recombination in swine or change that allows bird blu to directly infect humans
Proposed emergence of H1N1
- caused pandemic in 2009 (worldwide)
- 3 strains of influenza virus from different species
- recombination of flu genes in swine
Swine Influenza
- emerging disease